Immatics PRAME presentations at ESMO 2026
Analysis based on 6 articles · First reported Jul 17, 2026 · Last updated Jul 17, 2026
The announcement may positively impact Immatics' stock as it showcases progress in its PRAME pipeline. However, the event is a routine conference presentation, so market impact is likely limited.
Immatics announced three presentations at the ESMO Congress 2026, to be held in Madrid, Spain from October 23-27, 2026. The presentations will cover Phase 1b data from anzu-cel in melanoma, Phase 1 data from IMA203CD8 across solid tumors, and Phase 1b data from IMA402 bispecific at RP2D range. These highlight the breadth of Immatics' PRAME franchise across cell therapies and bispecifics.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard